Immunologic Difference between Hypersensitivity to Mosquito Bite and Hemophagocytic Lymphohistiocytosis Associated with Epstein-Barr Virus Infection

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Lee, Wen I ^a,b   Lin, Jainn Jim ^a,b   Hsieh, Meng Ying ^a,b   Lin, Syh Jae ^b   Jaing, Tang Her ^a   Chen, Shih Hsiang ^a   Hung, Iou Jih ^a   Yang, Chao Ping ^a   Chen, Chin Jung ^a   Huang, Yhu Chering ^a   Li, Shin Pai ^b   Huang, Jing Long ^a,b  

^a CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GRANZYME; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PERFORIN;

ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHILD; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS INFECTION; FEMALE; HEMOPHAGOCYTIC SYNDROME; HUMAN; HUMAN CELL; HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INSECT BITE; ITK GENE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; MOSQUITO; MUN13 4 GENE; NATURAL KILLER CELL; NONHUMAN; PFR1 GENE; PROTEIN EXPRESSION; SCHOOL CHILD; SH2D1A GENE; STX11 GENE; STXBP2 GENE; VIRUS GENE; VIRUS LOAD; XIAP GENE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CULICIDAE; CYTOTOXICITY, IMMUNOLOGIC; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FLOW CYTOMETRY; GRANZYMES; HERPESVIRUS 4, HUMAN; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULINS; INSECT BITES AND STINGS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; K562 CELLS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MEMBRANE PROTEINS; PERFORIN; SEQUENCE ANALYSIS, DNA;

EID: 84885826766     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076711     Document Type: Article

References (44)

1. Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, et al. (1984) Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A (81) (): 4510-4514.
2. Rickinson AB, Moss DJ, (1997) Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 15: 405-431.
3. Wilson AD, Redchenko I, Williams NA, Morgan AJ, (1998) CD4+ T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis. Int Immunol 10: 1149-1157.
4. Jones JF, (1989) A perspective of Epstein-Barr virus diseases. Adv Pediatr 36: 307-346.
5. Rickinson AB, Kieff E, Fields BN, Knipe DM, Howley PM, eds. Fields' virology. 3d ed. Vol 2. Philadelphia: Lippincott-Raven 1996: 2397-2446.
6. Rickinson AB, (1986) Chronic, symptomatic Epstein-Barr virus infections. Immunol Today 7: 13-14.
7. Ishihara S, Okada S, Wakiguchi H, Kurashige T, Morishima T, et al. (1995) Chronic active Epstein-Barr virus infection in children in Japan. Acta Paediatr 84: 1271-1275.
8. Straus SE, (1998) The chronic mononucleosis syndrome. J Infect Dis 157: 405-412.
9. Okano M, Matsumoto S, Osato T, Sakiyama Y, Thiele GM, et al. (1991) Severe chronic active Epstein-Barr virus infection syndrome. Clin Microbiol Rev 4: 129-135.
10. Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, et al. (2001) Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 98: 280-286.
11. Jones J, Shurin S, Abramowsky C, Tubbs RR, Sciotto CG, et al. (1988) T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 318: 733-741.
12. Kikuta H, Taguchi Y, Tomizawa K, Kojima K, Kawamura N, et al. (1988) Epstein-Barr virus genome positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333: 455-457.
13. Kawa-Ha K, Ishihara S, Ninomiya T, Yumura-Yagi K, Hara J, et al. (1989) CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 84: 51-55.
14. Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, et al. (2000) Fulminant EBV+ Tcell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood 96: 443-451.
15. Janka GE, Schneider EM, (2004) Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol 124: 4-14.
16. Côte M, Ménager MM, Burgess A, Mahlaoui N, Picard C, et al. (2009) Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest 119: 3765-3773.
17. Nichols KE, (2007) FHL4: NK cells pack less punch. Blood 110: 1705-1706.
18. Rigaud S, Fondanèche MC, Lambert N, Pasquier B, Mateo V, et al. (2006) XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature (444) (): 110-114.
19. Pachlopnik Schmid J, Canioni D, Moshous D, Touzot F, Mahlaoui N, et al. (2011) Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood 117: 1522-1529.
20. Huck K, Feyen O, Niehues T, Rüschendorf F, Hübner N, et al. (2009) Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J Clin Invest 119: 1350-1358.
21. Asada H, (2007) Hypersensitivity to mosquito bites: a unique pathogenic mechanism linking Epstein-Barr virus infection, allergy and oncogenesis. J Dermatol Sci 45: 153-160.
22. Pacheco SE, Gottschalk SM, Gresik MV, Dishop MK, Okmaura T, et al. (2005) Chronic active Epstein-Barr virus infection of natural killer cells presenting as severe skin reaction to mosquito bites. J Allergy Clin Immunol 116: 470-472.
23. Kimura H, Hoshino Y, Hara S, Sugaya N, Kawada J, et al. (2005) Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection. J Infect Dis 191: 531-539.
24. Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, et al. (2012) EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood 119: 673-686.
25. Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, et al. (2003) Pediatric AIDS Clinical Trials Group. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 112: 973-980.
26. Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES, (2008) Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol 20: 1472-1482.
27. Imadome K, Shimizu N, Arai A, Miura O, Watanabe K, et al. (2005) Coexpression of CD40 and CD40 ligand in Epstein-Barr virus-infected T and NK cells and their role in cell survival. J Infect Dis 192: 1340-1348.
28. Park S, Bahng S, Kim EK, Park SB, Sung YK, et al. (2010) Hodgkin's lymphoma arising in a patient with hypersensitivity to mosquito bites: a case report. J Clin Oncol 28: e148-150.
29. Zhang Z, Shi Q, An X, Ma H, Zhou H, et al. (2009) NK/T-cell lymphoma in a child with hypersensitivity to mosquito bites. J Pediatr Hematol Oncol 31: 855-857.
30. Tokura Y, Ishihara S, Tagawa S, Seo N, Ohshima K, et al. (2001) Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma. J Am Acad Dermatol 45: 569-578.
31. Tsai WC, Luo SF, Liaw SJ, Kuo TT, (1989) Mosquito bite allergies terminating as hemophagocytic histiocytosis: report of a case. Taiwan Yi Xue Hui Za Zhi 88: 639-642.
32. Asada H, Miyagawa S, Sumikawa Y, Yamaguchi Y, Itami S, et al. (2003) CD4+ T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis. Arch Dermatol 139: 1601-1607.
33. Gotoh K, Ito Y, Shibata-Watanabe Y, Kawada J, Takahashi Y, et al. (2008) Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation. Clin Infect Dis 46: 1525-1534.
34. Zhizhuo H, Junmei X, Yuelin S, Qiang Q, Chunyan L, et al. (2012) Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 58: 410-414.
35. Voskoboinik I, Sutton VR, Ciccone A, House CM, Chia J, et al. (2007) Perforin activity and immune homeostasis: the common A91V polymorphism in perforin results in both presynaptic and postsynaptic defects in function. Blood 110: 1184-1190.
36. Voskoboinik I, Thia MC, Trapani JA, (2005) A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis. Blood 105: 4700-4706.
37. Chuang HC, Lay JD, Hsieh WC, Wang HC, Chang Y, et al. (2005) Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. Blood 106: 3090-3096.
38. Kaech SM, Wherry EJ, Ahmed R, (2002) Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2: 251-262.
39. Abbas AK, Lichtman AH (2003) Antigen receptors and accessory molecules of T lymphocytes. In Cellular and Molecular immunology (5th eds). Philadelphia, WB Saunders, pp. 105-125.
40. Abbas AK, Lichtman AH (2003) Activatopn of T lymphocytes. In Cellular and Molecular immunology (5th eds). Philadelphia, WB Saunders, 163-188.
41. Chang YS, Tyan YS, Liu ST, Tsai MS, Pao CC, (1990) Detection of Epstein-Barr virus DNA sequences in nasopharyngeal carcinoma cells by enzymatic DNA amplification. J Clin Microbiol 28: 2398-2402.
42. Lin SJ, Cheng PJ, Huang YJ, Kuo ML, (2004) Evaluation of cytotoxic function and apoptosis in interleukin (IL)-12/IL-15-treated umbilical cord or adult peripheral blood natural killer cells by a propidium-iodide based flow cytometry. Pediatr Allergy Immunol 15: 79-85.
43. Lee WI, Kuo ML, Huang JL, Lin SJ, Wu CJ, (2005) Distribution and clinical aspects of primary immunodeficiencies in a Taiwan pediatric tertiary hospital during a 20-year period. J Clin Immunol 25: 162-173.
44. Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, et al. (2005) Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 105: 1881-1890.